# EDGAR Filing Document

**Accession Number:** 0000946644
**File Stem:** 0001493152-25-011374
**Filing Date:** 2025-7
**Character Count:** 2985
**Document Hash:** 5914f35a47d662136ff6efa5f2508674
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-011374.hdr.sgml**: 20250825

**ACCESSION NUMBER**: 0001493152-25-011374

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250724

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AIM ImmunoTech Inc.
- **CENTRAL INDEX KEY:** 0000946644
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 520845822
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 2117 SW HIGHWAY 484
- **CITY:** OCALA
- **STATE:** FL
- **ZIP:** 32801
- **BUSINESS PHONE:** 352-448-7797

**MAIL ADDRESS:**
- **STREET 1:** 2117 SW HIGHWAY 484
- **CITY:** OCALA
- **STATE:** FL
- **ZIP:** 32801

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEMISPHERX BIOPHARMA INC
- **DATE OF NAME CHANGE:** 19950614

![](formcorresp_001.jpg)

July 24, 2025

<u>VIA EDGAR</u>

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

---

| | |
|:---|:---|
| Re: | AIM ImmunoTech Inc. |
|  | Registration Statement on Form S-1 |
|  | <u>(SEC filing No. 333-284443)</u> |
|  | Acceleration Request |
|  | Requested Date: July 28, 2025 |
|  | Requested Time: 5:00 P.M. EDT |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), AIM ImmunoTech Inc. (the "Company") hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-284443) (the "Registration Statement") be declared effective at the "Requested Date" and "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission (the Commission").

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Silverman Shin & Byrne PLLC, by calling Richard Feiner, Esq. at (646) 822-1170. We also respectfully request that a copy of the written order from the Commission verifying the effective date and time of the Registration Statement be sent to Mr. Feiner via email at rfeiner@silverfirm.com.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| AIM IMMUNOTECH INC. | AIM IMMUNOTECH INC. |
| By: | */s/ Peter W. Rodino* |
|  | Peter W. Rodino, |
|  | Chief Operating Officer |

---

cc: Richard Feiner, Esq.

---

| | | | |
|:---|:---|:---|:---|
| Corporate Headquarters |  |  |  |
| 2117 SW Highway 484, Ocala FL 34473 |  | t: 352-448-7797 | f: 352-480-4620 |
| Human Resources and Administration |  |  |  |
| 604 Main Street, Riverton NJ 08077 |  | t: 352-448-7797 | f: 352-480-4620 |
| Operations, Research and Development |  |  |  |
| 671A US-1 South, North Brunswick, NJ 08902 | <u>www.aimimmuno.com</u> | t: 732-249-3250 | f: 732-249-6895 |

---